Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma. Réseau Comète INSERM.

Adrenocortical carcinoma (ACC) is a rare tumour with a poor prognosis. Cisplatin is the most widely tested cytotoxic agent in this disease. A total of 18 patients with advanced ACC were enrolled. Cytotoxic therapy consisted of etoposide (VP16) (100 mg m(-2) day(-1) on days 1-3) and cisplatin (100 mg...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bonacci, R., Gigliotti, A., Baudin, E., Wion-Barbot, N., Emy, P., Bonnay, M., Cailleux, A. F., Nakib, I., Schlumberger, M.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group|1 1998
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2063075/
https://ncbi.nlm.nih.gov/pubmed/9716042
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items